The invention relates to a compound of formula (I) wherein R1 to R4 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament. In particular, the compound may be used as a preferential agonist of Cannabinoid Receptor 2.
申请公布号
HRP20161702(T1)
申请公布日期
2017.02.10
申请号
HR2016P001702T
申请日期
2016.12.13
申请人
F. Hoffmann - La Roche AG
发明人
Bissantz, Caterina;Dhurwasulu, Baledi;Grether, Uwe;Hazra, Anindya;Hebeisen, Paul;Roever, Stephan;Rogers-Evans, Mark
